Atorvastatin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01076 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 41 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial hypercholesterolemia | KG + DL |
| 2 | HIV infectious disease | KG + DL |
| 3 | brain stem infarction | KG + DL |
| 4 | cholesterol-ester transfer protein deficiency | KG + DL |
| 5 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 6 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 7 | hypoalphalipoproteinemia | KG + DL |
| 8 | hypercholesterolemia, autosomal dominant | KG + DL |
| 9 | feline acquired immunodeficiency syndrome | KG + DL |
| 10 | simian immunodeficiency virus infection | KG + DL |
| 11 | ABri amyloidosis | KG + DL |
| 12 | fibroma of prostate | KG + DL |
| 13 | cerebral artery occlusion | KG + DL |
| 14 | cerebral arterial disease | KG + DL |
| 15 | hyperlipidemia due to hepatic triglyceride lipase deficiency | KG + DL |
| 16 | benign reproductive system neoplasm | KG + DL |
| 17 | Brenner tumor | KG + DL |
| 18 | benign prostate phyllodes tumor | KG + DL |
| 19 | prostate cancer/brain cancer susceptibility | KG + DL |
| 20 | generalized atherosclerosis | KG + DL |
| 21 | cerebral atherosclerosis | KG + DL |
| 22 | male reproductive organ cancer | KG + DL |
| 23 | familial hyperlipidemia | KG + DL |
| 24 | prostate leiomyoma | KG + DL |
| 25 | hypolipoproteinemia (disease) | KG + DL |
| 26 | hyperlipidemia | KG + DL |
| 27 | MRI defined brain infarct | KG + DL |
| 28 | coronary atherosclerosis | KG + DL |
| 29 | prostate neoplasm | KG + DL |
| 30 | cholesterol embolism | KG + DL |
| 31 | intracerebral hemorrhage | KG + DL |
| 32 | hyperalphalipoproteinemia | KG + DL |
| 33 | duodenal obstruction | KG + DL |
| 34 | female breast carcinoma | KG + DL |
| 35 | cardiac tamponade | KG + DL |
| 36 | ABeta amyloidosis | KG + DL |
| 37 | coronary artery disease | KG + DL |
| 38 | sitosterolemia | KG + DL |
| 39 | glaucoma | KG + DL |
| 40 | hypertriglyceridemia, familial | KG + DL |
| 41 | familial chylomicronemia syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.